Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has.
The PROACTIVE-HF 2 trial is designed to expand access to NYHA class II patients and to scale pulmonary artery pressure-guided therapy with the Cordella Sensor
Endotronix Announces Enrollment Completion of PROACTIVE-HF Pivotal Trial laragione.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laragione.eu Daily Mail and Mail on Sunday newspapers.
Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE